Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones.
- 1 January 1984
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 32 (7) , 2565-2570
- https://doi.org/10.1248/cpb.32.2565
Abstract
As part of a recent search for new semisynthetic analogs of maytransinoids having a better therapeutic ratio than maytansine [an antitumor agent], 3-epimaytansinoids (VIIa-c [3-epimaytansinol 3-isobutyrate, 3-epimaytansinol 3-n-octanoate and 3-epimaytansinol 3-phenylacetate]) were synthesized starting from ansamitocin P-3, a fermentation product of Nocardia sp., via maytansinol (I). A key intermediate, 3-epimaytansinol (VI), was synthesized by oxidation of I with pyridinium chlorochromate to 3-maytansinone (IV), followed by stereoselective reduction with NaBH4. Esterification of VI with appropriate carboxylic acids gave the corresponding 3-epimaytansinoids (VIIIa-c) in high yields. These compounds did not show the biological activity characteristic of natural maytansinoids to any appreciable degree.This publication has 3 references indexed in Scilit:
- Inhibition of Cilia Regeneration of Tetrahymena by Ansamitocins, New Antitumor AntibioticsAntimicrobial Agents and Chemotherapy, 1979
- Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoidsJournal of Medicinal Chemistry, 1978
- Tumor inhibitors. 122. The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolidesThe Journal of Organic Chemistry, 1977